byPhotosynthesis Technology: It's not just for plants! @photosynthesis Cultivating life through Photosynthesis, harnessing sunlight to nourish ecosystems and fuel a sustainable future. Cultivating ...

WASHINGTON — It is the time of year every college basketball fan waits for. March Madness is right around the corner. Sixty-eight men's and women’s teams will soon have their sights on raising the ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A pseudonym used by President Donald Trump in the 1980s and 90s popped ...

BARROW COUNTY, Ga. — The trial for the father of a teenager accused of opening fire inside his school in 2024, killing four and injuring more, is set to begin on Monday. Colin Gray faces nearly 30 ...

Selection of cattle is the process by which we determine which animals become parents, how many offspring they will produce and how long they will remain in our breeding herd. When we select ...

At a Tuesday meeting, the Office of Residential Life announced that it will shift its program and theme housing selection process to a randomized lottery, The Herald previously reported. In the days ...

As the world races to build artificial superintelligence, one maverick bioengineer is testing how much unprogrammed intelligence may already be lurking in our simplest algorithms to determine whether ...

Building owners and property managers will no longer be able to use algorithm-based software to artificially inflate New Yorkers’ rents as a result of a bill signed into law by Gov. Kathy Hochul on ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

The Command Assessment Program, or CAP, was used to “facilitate(s) the selection of battalion and brigade commanders, brigade command sergeants major, and medical service corps and acquisition corps ...

Recursion, a clinical-stage TechBio company, has successfully acquired Rallybio’s entire interest in their joint ENPP1 inhibitor program (REV102) aimed at treating hypophosphatasia (HPP), a rare ...